novo nordisk glp-1 receptor agonists weight management diabetes treatments cardinal health agonist GLP-1 receptor for type 2 diabetes and weight management novo nordisk glp-1 receptor agonist
Description
[DOI] [PubMed] [Google Scholar] 58.Witko-Sarsat V., Friedlander M., Capeillre-Blandin C., et al
Factors such as rapid weight reduction, caloric restriction, nutritional deficiencies, and metabolic changes all play contributory roles
10.2337/dc21-2064 Diabetes Care 18 Cukierman-YaffeT.GersteinH.ColhounH.DiazR.Garca-PrezL.LakshmananM.et al (2020)
New risks include increased aspiration risk during anesthesia due to delayed gastric emptying and challenges with bowel preparation for colonoscopies [50] [51] [52]
